endocrinologist glp 1 GLP-1 Agonists For Obesity In Non-Diabetic Patients: Game Changer Or Overhyped? A Critical Analysis GlobalRPH How GLP-1 use and eating

A systematic review and meta-analysis found that hibiscus extract significantly reduced systolic and diastolic blood pressure in clinical studies

Decision matrix Safety considerations researchers should know Both compounds are newer than established GLP-1 agonists , which means their long-term safety profiles are still being characterized

What this means for the future of healthcare in Westport This federal agreement represents one of the most significant steps toward national obesity and metabolic health reform

Diabetes Care 45(1):134141 Koekkoek PS, Kappelle LJ, van den Berg E, Rutten GE, Biessels GJ (2015) Cognitive function in patients with diabetes mellitus: guidance for daily care

GLP-1/GIP Therapy Discontinuation: Why the How Matters One of the most-discussed challenges with GLP-1/GIP agonists such as tirzepatide (Mounjaro) is weight regain after stopping therapy

Dolan is a bariatric and minimally invasive general surgeon, board-certified by the American Board of Surgery